Message from President and CEO

Dear Friends!

Welcome to The LAM Foundation's newly revamped Web site!  We are proud to share with you a new look and fresh content that we hope will offer even greater patient and caregiver support, a better understanding of current and future research, as well as new ways to get involved in the fight against LAM. 

Over the last 12 years, The LAM Foundation has worked to bring hope to all members of the LAM community, raising awareness among physicians and women, and acting as a resource for physicians and women with LAM.  Through our rigorous peer-review process and with help from some of the best medical minds in the world, we have made major scientific breakthroughs for LAM, including:

• First evidence of a genetic link between Tuberous Sclerosis and LAM
• Molecular explanation for abnormal smooth muscle cell growth in LAM
• Laboratory evidence that sirolimus inhibits the growth of LAM cells

And this is just the beginning!  The LAM Foundation is actively engaged in identifying potential targets and treatments for LAM.  We have recently launched the first-ever LAM treatment clinical trial - The Multicenter International LAM Efficacy of Sirolimus (MILES) Trial in Cincinnati. Sites in the United States, Canada and Japan are all in the process of opening.

We hope you will enjoy the new resources we have to offer and that we will inspire you to get involved in the fight against LAM.  Together we can - and will - beat this disease!

Sincerely,

Leslie Sullivan-Stacey
President and CEO

Learn more about the symptoms, cause and treatment of LAM.

Get ideas and advice on how you can support The LAM Foundation.

Read about the latest news and happenings in the LAM community.